TY  - JOUR

T1  - Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis

JO  - Value in Health

UR  - http://dx.doi.org/10.1016/j.jval.2023.01.018

PY  - 2023/02/09

AU  - Lackey LG

AU  - Ng X

AU  - Veldwijk J

AU  - Thokala P

AU  - Levitan B

AU  - Payne K

AU  - Ho M

AU  - Tervonen T

ED  - 

DO  - DOI: 10.1016/j.jval.2023.01.018

PB  - Elsevier BV

VL  - 26

IS  - 4

SP  - 519

EP  - 527

Y2  - 2024/10/23

ER  -